The Pennant Group (PNTG) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.35
- Estimate
- $0.35
- Surprise
- -1.2%
- Revenue (period 2026-09-30)
- $302.3M
- Score today
- 5.3/10
Revenue source: xbrl.
How the report landed
The Pennant Group (PNTG) reported adjusted EPS of $0.35, in line with the $0.35 estimate.
Coverage in the report window
- Oppenheimer Maintains Outperform Rating on The Pennant Group, Inc. — fiscal.ai, 2026-11-06
- Conference call: Pennant Gr Affirms FY2026 Adj EPS Guidance of $1.34-$1.41 vs $1.40 Est; Affirms FY2026 Sales Guidance o — benzinga, 2026-11-05
- Pennant Gr Q3 2026 Earnings Call Transcript — benzinga, 2026-11-05
Where TrendMatrix's rating stands now
TrendMatrix currently rates PNTG Sell at 5.3/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's -1.2% surprise compares with a +5.1% four-quarter average. Next scheduled report: 2027-02-24.
What argues against it
- Concentration risk — Regulatory: government payors (Medicare and Medicaid) (61.5%)
- Concentration risk — Regulatory: Medicare (hospice services) (87.0%)
- Quality below floor (3.0 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $37.81
- Price target
- $40.74
- Stop
- $35.16
- Upside to target
- +7.7%
- Reward-to-risk
- 0.7:1
The stock trades at 44.0× trailing but 25.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
PNTG at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $1.40B
- P/E (fwd)
- 25.2
- P/E (ttm)
- 44.0
- 52-week range
- $22.25–$44.24
- Off 52-week high
- 14.5%
- RSI (14)
- 42
- Volume vs avg
- 1.13×
- Score today
- 5.3/10